A novel method for development of malaria vaccines using full-length cDNA libraries (Q33218551)

24 July 2017

A novel method for development of malaria vaccines using full-length cDNA libraries (English)

1 reference

24 July 2017

1 reference

1 reference

Akiko Shibui

1

0 references

author name string

Takashi Shiibashi

2

1 reference

24 July 2017

Sadao Nogami

3

1 reference

24 July 2017

Sumio Sugano

4

1 reference

24 July 2017

Junichi Watanabe

5

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

24 July 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

24 July 2017

23

1 reference

24 July 2017

34

1 reference

24 July 2017

4359-4366

1 reference

Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei

24 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Malaria vaccine: candidate antigens, mechanisms, constraints and prospects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Heterologous protection against influenza by injection of DNA encoding a viral protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

A multilateral effort to develop DNA vaccines against falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Protection against mycoplasma infection using expression-library immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Expression library immunization protects mice against a challenge with virulent rodent malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

FULL-malaria: a database for a full-length enriched cDNA library from human malaria parasite, Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Full-malaria 2004: an enlarged database for comparative studies of full-length cDNAs of malaria parasites, Plasmodium species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Progress in the development of recombinant and synthetic blood-stage malaria vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

c-DNA vaccination against parasitic infections: advantages and disadvantages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Protection against murine cysticercosis using cDNA expression library immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Immunoregulation of malarial infection: balancing the vices and virtues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

Involvement of macrophage scavenger receptors in protection against murine malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

inferred from DOI database lookup

7 January 2021

based on heuristic

Resolution of acute malaria (Plasmodium berghei in the rat): reversibility and spleen dependence.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.036

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.03.036

1 reference

24 July 2017

1 reference